PT - JOURNAL ARTICLE AU - Tamara Matute AU - Isaac Nuñez AU - Maira Rivera AU - Javiera Reyes AU - Paula Blázquez-Sánchez AU - Aníbal Arce AU - Alexander J. Brown AU - Chiara Gandini AU - Jennifer Molloy AU - César A. Ramirez-Sarmiento AU - Fernán Federici TI - Homebrew reagents for low cost RT-LAMP AID - 10.1101/2021.05.08.21256891 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.08.21256891 4099 - http://medrxiv.org/content/early/2021/05/12/2021.05.08.21256891.short 4100 - http://medrxiv.org/content/early/2021/05/12/2021.05.08.21256891.full AB - RT-LAMP (reverse transcription - Loop-mediated isothermal amplification) has gained popularity for the detection of SARS-CoV-2. The high specificity, sensitivity, simple protocols and potential to deliver results without the use of expensive equipment has made it an attractive alternative to RT-PCR. However, the high cost per reaction, the centralized manufacturing of required reagents and their distribution under cold chain shipping limits RT-LAMP’s applicability in low-income settings. The preparation of assays using homebrew enzymes and buffers has emerged worldwide as a response to these limitations and potential shortages. Here, we describe the production of Moloney murine leukemia virus (M-MLV) Reverse Transcriptase and BstLF DNA polymerase for the local implementation of RT-LAMP reactions at low cost. These reagents compared favorably to commercial kits and optimum concentrations were defined in order to reduce time to threshold, increase ON/OFF range and minimize enzyme quantities per reaction. As a validation, we tested the performance of these reagents in the detection of SARS-CoV-2 from RNA extracted from clinical nasopharyngeal samples, obtaining high agreement between RT-LAMP and RT-PCR clinical results. The in-house preparation of these reactions results in an order of magnitude reduction in costs, and thus we provide protocols and DNA to enable the replication of these tests at other locations. These results contribute to the global effort of developing open and low cost diagnostics that enable technological autonomy and distributed capacities in viral surveillance.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://dx.doi.org/10.17504/protocols.io.bijzkcp6 https://dx.doi.org/10.17504/protocols.io.bsernbd6 https://dx.doi.org/10.17504/protocols.io.bksrkwd6 https://www.protocols.io/edit/low-cost-lamp-and-rt-lamp-bsejnbcn Funding StatementThis research was supported by ANID CONCYTEC covbio0012 and ANID Millennium Science Initiative Program ICN17_022. This work was further supported by the National Institutes of Health NIAID training grant (Training Program in Immunology; T32-AI07405) awarded to A. J. Brown. M. Rivera was funded by ANID FONDECYT 3190731 grant. P. Blazquez-Sanchez and J. Reyes were funded by ANID Doctoral Scholarship (ANID PFCHA 21191979 and 21191684, respectively)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The clinical samples were obtained from anonymous patients. All methods were performed in accordance with the relevant guidelines and regulations. All procedures were approved by the Ethics and Biosecurity Committee of Pontificia Universidad Catolica de Chile.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the following repository: https://zenodo.org/record/4540817#.YCnTO1NKj8o https://zenodo.org/record/4540817#.YCnTO1NKj8o